Patient Navigation for High-Risk Pregnancy
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Patient Navigation for High-Risk Pregnancy is an effective treatment?
The available research shows that Patient Navigation for High-Risk Pregnancy is effective in improving postpartum care, especially for low-income individuals. It helps bridge the gap between obstetric and primary care, ensuring better care coordination and patient engagement. This treatment is particularly beneficial in addressing social and structural barriers to healthcare, leading to improved health outcomes. While the evidence is still emerging, it suggests that patient navigation can enhance health and patient-reported outcomes during and after the postpartum period.12345
What safety data exists for patient navigation in high-risk pregnancy?
The provided research does not directly address safety data for patient navigation in high-risk pregnancy. However, it highlights the potential benefits of patient navigation in improving postpartum care, especially for low-income individuals. The studies suggest that patient navigation is a promising method to enhance health outcomes by addressing barriers to care, but specific safety data is not detailed in the abstracts.12346
Is the treatment 'Community-based prenatal/perinatal/postpartum patient navigator, Standard of Care' a promising treatment for high-risk pregnancy?
What is the purpose of this trial?
This study will test the effectiveness of a community-based patient navigator intervention from mid-pregnancy through 12 month postpartum for a high-risk population of medically underserved women. The RCT will enroll 540 pregnant women before 20 weeks of pregnancy and randomly allocate them into two different study arms from the time of prenatal enrollment through 12 months postpartum. If found to be effective, the community-based patient navigator intervention can be implemented as a standard of care at Grady and other provider practices serving high-risk women to improve maternal health outcomes and reduce racial disparities.
Research Team
Anne L Dunlop, MD
Principal Investigator
Emory University
Eligibility Criteria
This trial is for Black, English-speaking pregnant women or individuals over 18 years old with Medicaid coverage. They must be less than 20 weeks pregnant with a single baby and have at least one unmet social need. Participants should plan to receive care and deliver at Grady, staying available through the first year postpartum.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Intervention
Participants receive a community-based patient navigator with 3 prenatal contacts offering health assessment, education, and social support
Postpartum Intervention
Participants continue with the community-based patient navigator with 5 postpartum contacts offering health assessment, education, and social support
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Community-based prenatal/perinatal/postpartum patient navigator
- Standard of Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator